1. Home
  2. ACTU vs CLAR Comparison

ACTU vs CLAR Comparison

Compare ACTU & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • CLAR
  • Stock Information
  • Founded
  • ACTU 2015
  • CLAR 1957
  • Country
  • ACTU United States
  • CLAR United States
  • Employees
  • ACTU N/A
  • CLAR N/A
  • Industry
  • ACTU
  • CLAR Recreational Games/Products/Toys
  • Sector
  • ACTU
  • CLAR Consumer Discretionary
  • Exchange
  • ACTU NYSE
  • CLAR Nasdaq
  • Market Cap
  • ACTU 135.0M
  • CLAR 150.4M
  • IPO Year
  • ACTU 2024
  • CLAR N/A
  • Fundamental
  • Price
  • ACTU $8.00
  • CLAR $3.26
  • Analyst Decision
  • ACTU Strong Buy
  • CLAR Strong Buy
  • Analyst Count
  • ACTU 1
  • CLAR 4
  • Target Price
  • ACTU $20.00
  • CLAR $5.75
  • AVG Volume (30 Days)
  • ACTU 42.0K
  • CLAR 205.4K
  • Earning Date
  • ACTU 05-21-2025
  • CLAR 05-01-2025
  • Dividend Yield
  • ACTU N/A
  • CLAR 3.07%
  • EPS Growth
  • ACTU N/A
  • CLAR N/A
  • EPS
  • ACTU N/A
  • CLAR N/A
  • Revenue
  • ACTU N/A
  • CLAR $264,315,000.00
  • Revenue This Year
  • ACTU N/A
  • CLAR N/A
  • Revenue Next Year
  • ACTU N/A
  • CLAR $10.96
  • P/E Ratio
  • ACTU N/A
  • CLAR N/A
  • Revenue Growth
  • ACTU N/A
  • CLAR N/A
  • 52 Week Low
  • ACTU $5.51
  • CLAR $3.25
  • 52 Week High
  • ACTU $11.73
  • CLAR $7.55
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • CLAR 28.91
  • Support Level
  • ACTU N/A
  • CLAR $3.25
  • Resistance Level
  • ACTU N/A
  • CLAR $3.56
  • Average True Range (ATR)
  • ACTU 0.00
  • CLAR 0.22
  • MACD
  • ACTU 0.00
  • CLAR -0.01
  • Stochastic Oscillator
  • ACTU 0.00
  • CLAR 1.72

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: